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Abstract: Acetate, which is an abundant carbon source, is a potential feedstock for microbial processes
that produce diverse value-added chemicals. In this study, we produced 3-hydroxypropionic acid
(3-HP) from acetate with engineered Escherichia coli. For the efficient conversion of acetate to
3-HP, we initially introduced heterologous mcr (encoding malonyl-CoA reductase) from Chloroflexus
aurantiacus. Then, the acetate assimilating pathway and glyoxylate shunt pathway were activated
by overexpressing acs (encoding acetyl-CoA synthetase) and deleting iclR (encoding the glyoxylate
shunt pathway repressor). Because a key precursor malonyl-CoA is also consumed for fatty acid
synthesis, we decreased carbon flux to fatty acid synthesis by adding cerulenin. Subsequently, we
found that inhibiting fatty acid synthesis dramatically improved 3-HP production (3.00 g/L of 3-HP
from 8.98 g/L of acetate). The results indicated that acetate can be used as a promising carbon source
for microbial processes and that 3-HP can be produced from acetate with a high yield (44.6% of the
theoretical maximum yield).
Keywords: metabolic engineering; synthetic biology; 3-hydroxypropionic acid; microbial production;
fatty acid synthesis; acetate
1. Introduction
Microbial conversion is a highly promising process for the production of diverse value-added
chemicals and as an alternative to petroleum-based processes [1,2]. Specifically, it can utilize a variety
of sugars such as glucose, galactose, xylose and glycerol, which are plentiful in nature and readily
available as industrial waste, as a feedstock [3–5]. In addition to these sugars, acetate can be used
as a carbon source. Acetate is cheap and greatly abundant, as it can be obtained from biomass
hydrolysate or from the conversion of various single-carbon gases [6–8]. Therefore, the use of acetate
may reduce the cost of feedstock and thereby facilitate the development of more economic processes.
In this regard, several recent studies attempted to engineer microorganisms and demonstrated the
successful conversion of acetate into value-added chemicals such as itaconic acid, succinic acid and
fatty acid [9–11].
3-Hydroxypropionic acid (3-HP) is one of the important platform chemicals that can be produced
by microbial fermentation [12,13]. As 3-HP consists of two functional groups (a hydroxyl and carboxylic
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group), it can be easily converted to other chemicals (e.g., acrylic acid, acrylamide, and propiolactone)
for which there are huge markets [12]. Due to its production from sugars, several metabolic pathways
have been suggested to date [12,13]. While the representative route is the coenzyme-B12-dependent
dehydration of glycerol [14,15], it is only applicable when the feedstock is glycerol. Alternatively, 3-HP
can be produced via the reduction of malonyl-CoA using malonyl-CoA reductase (Figure 1) [16–18].
This pathway is suitable for most carbon sources, including acetate, because malonyl-CoA is a universal
intermediate in cells [16,17]. Additionally, this pathway does not require an expensive cofactor,
coenzyme B12, which is a potential hurdle for the economic production of 3-HP [18,19].
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To achieve the efficient conversion of acetate to 3-HP, acetate should be rapidly utilized. However,
microorganisms slowly utilize acetate as a carbon source and exhibit reduced cell growth [20,21].
Therefore, acetate assimilation and biomass formation should be accelerated via genetic engineering [11,22–24].
Furthermore, once acetate is assimilated, malonyl-CoA has to be sufficiently converted to 3-HP.
However, the primary use of malonyl-CoA in microorganisms is to synthesize fatty acids, which
significantly reduces 3-HP production [25–27]. Thus, acetate consumption for fatty acid synthesis
should be reduced to improve 3-HP production.
In this study, we demonstrated the efficient conversion of acetate to 3-HP by engineering a
representative microorganism, Escherichia coli. Initially, we constructed a synthetic 3-HP production
pathway with maximal expression of heterologous mcr (encoding malonyl-CoA reductase) from
Chloroflexus aurantiacus. To accelerate acetate consumption, we activated both the acetate assimilating
pathway and glyoxylate shunt pathway by amplifying acs, which encodes acetyl-CoA synthetase, and
deleting iclR, which encodes the transcriptional repressor of the glyoxylate shunt pathway operon.
Additionally, to enhance the conversion of malonyl-CoA to 3-HP, carbon flux into a competing
pathway (i.e., fatty acid biosynthesis) was inhibited by adding cerulenin at different concentrations.
Consequently, we demonstrated that 3-HP could be efficiently produced from acetate using the
engineered microbial process.
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2. Results
2.1. Heterologous Expression of mcr for 3-HP Production from Acetate
For 3-HP production, we introduced mcr from C. aurantiacus into the E. coli strain BL21(DE3)
(Figure 1). To increase carbon flux toward 3-HP biosynthesis, we expressed mcr at a maximum level.
Specifically, we developed a synthetic cassette with a strong inducible promoter (Ptac) and a synthetic
5′ UTR (Table 1) designed using UTR Designer [28] to ensure high transcription and translation levels.
Furthermore, we used the pETDuet plasmid, which has a high copy number (~40 copies per cell),
to ensure its overexpression. Additionally, we introduced 3 point mutations (N940V, K1106W, S1114R)
known to enhance the activity of malonyl-CoA reductase [16].
Table 1. Synthetic 5′ UTR for gene expression.
Gene 5′ UTR sequence (5′−3′) a Predicted Expression Level (a.u.)
mcr AACAATTACTAGTAAGGAGAGGAGT 3,110,669.92
acs AAAATCAGCGCCCAAGGAGTCACCG b 1,074,836.02
a 5′ UTR sequences were designed using UTR Designer [26]. b This sequence was originally designed in a previous
study [9].
Following this, we cultivated the HJ1 strain (Table 2), which is BL21(DE3) with the constructed
plasmid (pET-mcr*), in modified minimal medium. After 48 h of fermentation, the HJ1 strain consumed
8.55 g/L of acetate and produced 95.7 mg/L of 3-HP (Figure 2). Although we successfully produced
3-HP from acetate with this engineered E. coli strain, the achieved titer was too low (1.49% of the
theoretical maximum yield). Thus, the strain required further engineering to improve 3-HP production
with efficient acetate utilization.
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Figure 2. Time-course fermentation profile of the HJ1 strain. The left y-axis, right y-axis and right y-
offset represent the cell biomass (g DCW/L), acetate (g/L) and 3-HP (g/L), respectively. The x-axis 
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indicate standard deviations for measurements from three independent cultures. One OD600 unit 
corresponds to 0.31 g dry cell weight (g DCW/L). 
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Compared to that of other sugars, the assimilation rate of acetate in microorganisms is relatively 
low [8]. Therefore, we investigated the effect of activating the acetate assimilation pathway on 3-HP 
production. To improve acetate uptake during the entire fermentation period, we expressed acs 
(encoding acetyl-CoA synthetase) with a synthetic expression cassette consisting of the strong 
constitutive promoter (PJ23100) and a synthetic 5′ UTR (Table 1). The synthetic expression cassette was 
inserted into the pACYCDuet plasmid, which has a moderate copy number (10–12 copies/cell), and 
the pACYC-Acs plasmid was introduced into the HJ1 strain, resulting in the HJ2 strain. Compared 
Figure 2. Ti e-course fer entation profile of the HJ1 strain. The left y-axis, right y-axis and right
y-offset represent the cell biomass (g C /L), acetate (g/L) and 3- P (g/L), respectively. The x-axis
denotes time (h). Symbols: circles, cell biomass; squares, acetate; triangles, 3-HP. The error bars indicate
standard deviations for measurements from three independent cultures. One OD600 unit corresponds
to 0.31 g dry cell weight (g DCW/L).
2.2. Engineering the Acetate Assimilation and Glyoxylate Shunt Pathways
Compared to that of other sugars, the assimilation rate of acetate in microorganisms is relatively
low [8]. Therefore, we investigated the effect of activating the acetate assimilation pathway on
3-HP production. To improve acetate uptake during the entire fermentation period, we expressed
acs (encoding acetyl-CoA synthetase) with a synthetic expression cassette consisting of the strong
constitutive promoter (PJ23100) and a synthetic 5′ UTR (Table 1). The synthetic expression cassette was
inserted into the pACYCDuet plasmid, which has a moderate copy number (10–12 copies/cell), and
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the pACYC-Acs plasmid was introduced into the HJ1 strain, resulting in the HJ2 strain. Compared to
the HJ1 strain, the HJ2 strain showed increased acetate consumption (a 1.11-fold increase) and cell
biomass (a 1.90-fold increase), indicating that acetate assimilation was successfully expedited by acs
overexpression (Figure 3A,B). Furthermore, the improved acetate assimilation in the HJ2 strain led to a
1.75-fold increase in 3-HP production (0.17 g/L, Figure 3C).
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Despite the elevated acetate consumption level, the 3-HP titer was still low, indicating the 
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decided to inhibit fatty acid synthesis to increase the intracellular malonyl-CoA pool for 3-HP 
production (Figure 1). Bacterial fatty acid synthesis can be inhibited by the addition of cerulenin, 
which binds to FabB and FabF and irreversibly inactivates them [31–33]. Thus, we cultivated the HJ4 
strain with the addition of different levels of cerulenin (10, 25, 50 and 100 μM) to gradually reduce 
carbon flux from malonyl-CoA to fatty acids. As expected, the addition of cerulenin was unfavorable 
for cell growth (Figure 4A–C). On the other hand, notably, it was highly beneficial for 3-HP 
production, as the titers and yields were dramatically increased. Specifically, when 50 μM of 
cerulenin was added, the HJ4 strain produced 3.00 g/L of 3-HP while consuming 8.98 g/L of acetate 
(0.30 g/g, 44.6% of the maximum theoretical yield, Figure 4D). This titer was 12.0-fold higher 
compared to the 3-HP titer produced by the same strain without cerulenin addition. These results 
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We then evaluated the effect of activating the glyoxylate shunt pathway. Because the glyoxylate
shunt pathway is responsible for a key anaplerotic reaction during acetate utilization, we expected
that its activation would facilitate biomass formation and improve acetate consumption. To investigate
this effect, we deleted chromosomal iclR, which is known to repress the expression of aceBAK in the
glyoxylate shunt pathway [11,29,30], in the HJ1 strain. Similar to the results for the overexpression of
acs, the acetate consumption and cell biomass of the resultant HJ3 strain were enhanced 1.09-fold and
1.31-fold, respectively (Figure 3A,B). These results indicated that iclR deletion successfully enhanced
cell biomass synthesis from acetate, which resulted in increased overall acetate consumption.
When the overexpression of acs and deletion of iclR were combined, the acetate uptake rate
(1.16-fold increase) and cell biomass (2.61-fold increase) were further enhanced (HJ4 strain, Figure 3A,B).
Moreover, its 3-HP production was synergistically improved 2.54-fold (0.25 g/L) compared to that
of the HJ1 strain (Figure 3C). Consequently, the combination of acs overexpression and iclR deletion
resulted in the most significant improvement in acetate assimilation and 3-HP production. However,
despite the improvement, only a small amount of acetate was converted to 3-HP (3.35% of the
theoretical maximum yield), indicating that further flux control is required for the efficient conversion
of acetate to 3-HP.
2.3. Improved 3-HP Production from Acetate by Inhibiting Fatty Acid Synthesis
Despite the elevated acetate consumption level, the 3-HP titer was still low, indicating the inefficient
conversion of malonyl-CoA due to leakage toward fatty acid synthesis. Therefore, we decided to inhibit
fatty acid synthesis to increase the intracellular malonyl-CoA pool for 3-HP production (Figure 1).
Bacterial fatty acid synthesis can be inhibited by the addition of cerulenin, which binds to FabB and
FabF and irreversibly inactivates them [31–33]. Thus, we cultivated the HJ4 strain with the addition of
different levels of cerulenin (10, 25, 50 and 100 µM) to gradually reduce carbon flux from malonyl-CoA
to fatty acids. As expected, the addition of cerulenin was unfavorable for cell growth (Figure 4A–C).
On the other hand, notably, it was highly beneficial for 3-HP production, as the titers and yields were
dramatically increased. Specifically, when 50 µM of cerulenin was added, the HJ4 strain produced
3.00 g/L of 3-HP while consuming 8.98 g/L of acetate (0.30 g/g, 44.6% of the maximum theoretical
yield, Figure 4D). This titer was 12.0-fold higher compared to the 3-HP titer produced by the same
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strain without cerulenin addition. These results indicated that 3-HP production from acetate was
successfully improved by inhibiting fatty acid biosynthesis and that flux control around malonyl-CoA
was critical for the efficient conversion of acetate to 3-HP.
Table 2. Bacterial strains and plasmids used in this study.
Name Description Source
Strains
Mach1-T1R E. coli F− ϕ80(lacZ)∆M15 ∆lacX74 hsdR(rK−mK+) ∆recA1398 endA1 tonA Invitrogen
BL21(DE3) E. coli F− ompT gal dcm lon hsdSB (rB− mB−) λ(DE3) Invitrogen
HJ1 BL21(DE3)/pET-mcr* This study
HJ2 BL21(DE3)/pET-mcr*/pACYC-acs This study
HJ3 BL21(DE3) ∆iclR/pET-mcr* This study
HJ4 BL21(DE3) ∆iclR/pET-mcr*/pACYC-acs This study
Plasmids
PLB0110 Source of mcr [15]
pETDuet Expression vector, ColE1 ori, AmpR Novagen
pACYCDuet Expression vector, p15A ori, CmR Novagen
pKD46 Red recombinase expression vector, AmpR [32]
pFRT72variant Source of mutant FRT-kanR-FRT [33]
pCP20 FLP expression vector, AmpR, CmR [32]
pET-mcr* pETDuet/Ptac-SynUTRmcr-mcr N940V, K1106W, S1114R This study
pACYC-acs pACYCDuet/PBBa_J23100-SynUTRacs-acs This study
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3. Discussion
In this study, we developed a microbial process for the conversion of acetate to 3-HP. Initially,
we introduced mcr at a maximum expression level to enable 3-HP production by an E. coli strain.
In addition, acetate consumption was expedited by engineering the acetate assimilating pathway and
glyoxylate shunt pathway. Furthermore, we increased carbon flux to the 3-HP production pathway by
inhibiting fatty acid synthesis with the addition of cerulenin. These efforts allowed us to efficiently
convert 8.98 g/L of acetate to 3.00 g/L of 3-HP. This is the first report on producing 3-HP from
acetate, and the achieved yield (0.30 g/g, 44.6% of the maximum theoretical yield) was superior to the
previously reported value (0.19 g/g) with glucose utilization [16].
To further improve the 3-HP production in E. coli, it could be more engineered. For example,
the activity of heterologous malonyl-CoA reductase from C. aurantiacus could be improved by codon
optimization of the mcr coding sequence. A number of previous studies have shown that codon
optimization can elevate the activities of heterologous enzymes [34–36]. Thus, codon optimization
of mcr would further enhance 3-HP production by expediting the conversion of malonyl-CoA to
3-HP. Furthermore, because production of 3-HP from acetate requires energy and reducing cofactor,
their stable supplementation should be achieved by balancing between the TCA cycle and 3-HP
synthesis. Therefore, the fine-tuning of flux toward the TCA cycle should be critical for 3-HP
production. Moreover, based on the results obtained in this study, reduction of the flux to fatty
acid synthesis may enhance the production of diverse malonyl-CoA-derived biochemicals in E. coli.
4. Materials and Methods
4.1. Reagents
Oligonucleotides, which are listed in Table 1, were synthesized by Cosmogenetech (Seoul, Korea).
Plasmid DNA and genomic DNA were purified using ExpinTM Plasmid SV and ExpinTM Cell SV
kits (GeneAll Biotechnology, Seoul, Korea). PCR products were purified using ExpinTM Gel SV kits
(GeneAll). Restriction enzymes were purchased from New England Biolabs (Ipswich, MA, USA).
Cerulenin was purchased from Cayman Chemical (Ann Arbor, MI, USA). 3-HP was obtained from
Tokyo Chemical Industry (Tokyo, Japan). Other chemical reagents were purchased from Sigma-Aldrich
(St. Louis, MO, USA).
4.2. Plasmid Cloning and Bacterial Strain Construction
All bacterial strains and plasmids used in this study are summarized in Table 2. Synthetic 5′
untranslated regions (5′ UTRs) were generated by UTR Designer [28] and are listed in Table 3. E. coli
Mach1-T1R (Invitrogen, Carlsbad, CA, USA) was used as a cloning host. To construct the pET-mcr*
plasmid, mcr was initially amplified from the PLB0110 plasmid [17] using the O-mcr-F1, O-mcr-F2,
and O-mcr-B primers to attach a strong inducible promoter (Ptac) and a synthetic 5′ UTR. Then, the
amplified fragment was digested with BamHI and XhoI endonucleases and inserted into the pETDuet
plasmid. It should be noted that the coding sequence of mcr was modified from its original sequence
via conventional site-directed mutagenesis using the O-N940V-F and O-N940V-B, O-K1106W-F and
O-K1106W-B, and O-S1114R-F and O-S1114R-B primer pairs for the introduction of N940V(AAT to
GTG), K1106W (AAG to TGG), and S1114R (AGT to CGT) mutations, respectively [16].
To construct the pACYC-acs plasmid, acs was amplified from the genomic DNA of E. coli
BL21(DE3) and attached to the BBa_J23100 promoter obtained from the Registry of Standard Biological
Parts (http://parts.igem.org) and a synthetic 5′ UTR using the O-Acs-F and O-Acs-B primers. The
amplified fragment was digested using EcoRI and SacI restriction enzymes and introduced into the
pACYCDuet plasmid.
Genome manipulation was conducted using the Lambda-Red recombination method with the
pKD46 plasmid [37]. Chromosomal iclR was deleted by inserting a FRT-kanR-FRT fragment that was
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amplified using the R-iclR-F and R-iclR-B primer pair. The integrated kanamycin resistance gene was
removed by expression of the flippase from the pCP20 plasmid.
Table 3. Oligonucleotides used in this study.
Name Sequence (5′−3′)
O-mcr-F1 GGAATTGTGAGCGGATAACAATTACTAGTAAGGAGAGGAGTATGAGCGGAACAGGACGACT
O-mcr-F2 GGATCCTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATT
O-mcr-B CTCGAGTGCGAAAAAACCCCGCCGAAGCGGGGTTTTTTGCGGCATGCTTACACGGTAATCGCCCGT
O-N940V-F TATTACCTTGCCGACCGCAATGTCAGTGGTGAGACATTCC
O-N940V-B GCGGTCGGCAAGGTAATAG
O-K1106W-F ATTTCCGGGTAGCGCGCAAGATTGCCCTGAGTGATGGTG
O-K1106W-B GCGCGCTACCCGGAAATG
O-S1114R-F TGAGTGATGGTGCCAGTCTCGCGCTGGTCACTC
O-S1114R-B AGACTGGCACCATCACTCAGGGC
O-acs-F GAATTCTTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGCAAAATCAGCGCCCAAGGAGTCACCGATGAGCCAAATTCACAAACACA
O-acs-B GAGCTCAAAAAAAACCCCGCCCTGTCAGGGGCGGGGTTTTTTTTTTTACGATGGCATCGCGATAG
R-iclR-F TGCCACTCAGGTATGATGGGCAGAATATTGCCTCTGCCCGCCAGAAAAAGGCATGACCGGCGCGATGC
R-iclR-B TAACAATAAAAATGAAAATGATTTCCACGATACAGAAAAAGGAGACTGTCGCTCAGCGGATCTCATGCGC
C-iclR-F CAACATTAACTCATCGGATCAG
C-iclR-B TCTATTGCCACTCAGGTATGATGGGC
4.3. Cultivation Methods
Cells were cultivated in a modified minimal medium consisting of 100 mM phosphate buffer
(pH 7.0), 1.0 g/L NaCl, 1.0 g/L NH4Cl, 0.5 g/L MgSO4·7H2O, and 1.0 g/L yeast extract. Pre-neutralized
10 g/L acetate with NaOH was used as a carbon source. To initiate a culture, a single colony was
inoculated into 3 mL of the medium in a test-tube. After an overnight incubation, the turbid culture
was refreshed by re-inoculating into fresh medium. When the OD600 reached ~1.0, the refreshed seed
was transferred to a 25 mL medium in a 300 mL flask until an OD600 of 0.05 was obtained. Genes
under the Ptac promoter were expressed by the addition of 0.1 mM IPTG when the OD600 reached 1.
At this time, different amounts of cerulenin were also added to inhibit fatty acid synthesis. The pH
was adjusted by adding 5 M of HCl with a 12 h interval during 48 h of culture. The plasmids were
maintained by adding 50 µg/mL ampicillin, 34 µg/mL chloramphenicol, and 50 µg/mL streptomycin.
All cell cultures were conducted with three biological replicates.
4.4. Analytical Methods
To monitor the cell growth, OD600 was measured using a UV-1700 spectrophotometer (Shimadzu,
Kyoto, Japan). Acetate and 3-HP were quantified using an Ultimate 3000 high-performance liquid
chromatography (HPLC) system (Dionex, Sunnyvale, CA, USA). To separate the metabolites, Aminex
HPX-87H (Bio-Rad Laboratories, Richmond, CA, USA) was used with 5 mM H2SO4 solution as a
mobile phase (0.6 mL/min). The temperature of the column oven was set to 14 ◦C. Refractive index
signals were measured using a Shodex RI-101 detector (Shodex, Klokkerfaldet, Denmark).
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4.5. Calculation of the Theoretical Maximum Yield
Initially, 1 mol acetate could be converted into 1 mol acetyl-CoA with the generation of 1 mol AMP
from 1 mol ATP via the Acs pathway. The generation of 1 mol AMP was equivalent to the consumption
of 2 mol ATP (Equation (1)). Next, 1 mol malonyl-CoA was produced from 1 mol acetyl-CoA with
the consumption of an additional 1 mol ATP. Finally, 1 mol malonyl-CoA was converted into 1 mol
3-HP with the consumption of 2 mol NADPH (Equation (3)). Therefore, 3 mol ATP and 2 mol NADPH
were required to produce 3-HP from acetate (Equation (4)). They could be obtained from the TCA
cycle with the oxidation of 1 mol acetate (1 mol NADH is equivalent to 2.5 mol ATP; 1 mol FADH
is equivalent to 1.5 mol ATP; 1 mol GTP is equivalent to 1 mol ATP; 1 mol NADH is equivalent to
1 mol NADPH) (Equations (1), (5) and (6)). Consequently, the production of 1 mol 3-HP required 2 mol
acetate (Equation (7), 50% mol/mol and 0.75 g/g).
Acetate + 2 ATP + CoA→ Acetyl-CoA + 2 ADP + 2 Pi (1)
Acetyl-CoA + ATP + CO2 →Malonyl-CoA + ADP + Pi (2)
Malonyl-CoA + 2 NADPH→ 3-HP + 2 NADP+ + CoA (3)
Acetate + CO2 + 3 ATP + 2 NADH→ 3-HP + 3 ADP + 3 Pi + 2 NAD+ (4)
Acetyl-CoA + 3 NAD+ + FAD+ + GDP + Pi → 2 CO2 + 3 NADH + FADH + GTP + CoA (5)
Acetate + 2 NADP+ → 2 CO2 + 2 NADPH + 3 ATP (6)
2 Acetate→ 3-HP + CO2 (7)
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